Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 60

Similar articles for PubMed (Select 23170275)


Rapamycin: A rheostat for CD8(+) T-cell-mediated tumor therapy.

Srivastava RK, Utley A, Shrikant PA.

Oncoimmunology. 2012 Oct 1;1(7):1189-1190.


Rapamycin Impairs Antitumor CD8+ T-cell Responses and Vaccine-Induced Tumor Eradication.

Chaoul N, Fayolle C, Desrues B, Oberkampf M, Tang A, Ladant D, Leclerc C.

Cancer Res. 2015 Jun 29. [Epub ahead of print]


Rapamycin: could it enhance vaccine efficacy?

Nam JH.

Expert Rev Vaccines. 2009 Nov;8(11):1535-9. doi: 10.1586/erv.09.115. Review.


Fine-tuning CD8(+) T cell functional responses: mTOR acts as a rheostat for regulating CD8(+) T cell proliferation, survival and differentiation?

Rao RR, Li Q, Shrikant PA.

Cell Cycle. 2010 Aug 1;9(15):2996-3001. doi: 10.4161/cc.9.15.12359. Epub 2010 Aug 12.


Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.

Best SR, Peng S, Juang CM, Hung CF, Hannaman D, Saunders JR, Wu TC, Pai SI.

Vaccine. 2009 Sep 4;27(40):5450-9. doi: 10.1016/j.vaccine.2009.07.005. Epub 2009 Jul 19.


Differential regulation of simultaneous antitumor and alloreactive CD8(+) T-cell responses in the same host by rapamycin.

Maleki Vareki S, Harding MJ, Waithman J, Zanker D, Shivji AN, Rytelewski M, Mazzuca DM, Yekta MA, Chen W, Schell TD, Haeryfar SM.

Am J Transplant. 2012 Jan;12(1):233-9. doi: 10.1111/j.1600-6143.2011.03811.x. Epub 2011 Oct 25.


Microneedle array design determines the induction of protective memory CD8+ T cell responses induced by a recombinant live malaria vaccine in mice.

Carey JB, Pearson FE, Vrdoljak A, McGrath MG, Crean AM, Walsh PT, Doody T, O'Mahony C, Hill AV, Moore AC.

PLoS One. 2011;6(7):e22442. doi: 10.1371/journal.pone.0022442. Epub 2011 Jul 25.


The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin.

Rao RR, Li Q, Odunsi K, Shrikant PA.

Immunity. 2010 Jan 29;32(1):67-78. doi: 10.1016/j.immuni.2009.10.010. Epub 2010 Jan 7.


Development of tumor-infiltrating CD8+ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-β blockade during the perioperative period of tumor resection.

Bellavance EC, Kohlhapp FJ, Zloza A, O'Sullivan JA, McCracken J, Jagoda MC, Lacek AT, Posner MC, Guevara-Patino JA.

J Immunol. 2011 Mar 15;186(6):3309-16. doi: 10.4049/jimmunol.1002549. Epub 2011 Feb 2.


Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cells.

Rubinstein MP, Kadima AN, Salem ML, Nguyen CL, Gillanders WE, Cole DJ.

J Immunol. 2002 Nov 1;169(9):4928-35.


A DNA vaccine encoding multiple HIV CD4 epitopes elicits vigorous polyfunctional, long-lived CD4+ and CD8+ T cell responses.

Rosa DS, Ribeiro SP, Almeida RR, Mairena EC, Postól E, Kalil J, Cunha-Neto E.

PLoS One. 2011 Feb 11;6(2):e16921. doi: 10.1371/journal.pone.0016921.


Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques.

Halwani R, Boyer JD, Yassine-Diab B, Haddad EK, Robinson TM, Kumar S, Parkinson R, Wu L, Sidhu MK, Phillipson-Weiner R, Pavlakis GN, Felber BK, Lewis MG, Shen A, Siliciano RF, Weiner DB, Sekaly RP.

J Immunol. 2008 Jun 15;180(12):7969-79.


Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccines.

Bassett JD, Swift SL, VanSeggelen H, Hammill JA, McGray AJ, Evelegh C, Wan Y, Bramson JL.

Mol Ther. 2012 Apr;20(4):860-9. doi: 10.1038/mt.2011.281. Epub 2011 Dec 20.


Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.

Welters MJ, Kenter GG, Piersma SJ, Vloon AP, Löwik MJ, Berends-van der Meer DM, Drijfhout JW, Valentijn AR, Wafelman AR, Oostendorp J, Fleuren GJ, Offringa R, Melief CJ, van der Burg SH.

Clin Cancer Res. 2008 Jan 1;14(1):178-87. doi: 10.1158/1078-0432.CCR-07-1880.


The context of epitope presentation can influence functional quality of recalled influenza A virus-specific memory CD8+ T cells.

Day EB, Zeng W, Doherty PC, Jackson DC, Kedzierska K, Turner SJ.

J Immunol. 2007 Aug 15;179(4):2187-94.


Vaccine-induced effector-memory CD8+ T cell responses predict therapeutic efficacy against tumors.

van Duikeren S, Fransen MF, Redeker A, Wieles B, Platenburg G, Krebber WJ, Ossendorp F, Melief CJ, Arens R.

J Immunol. 2012 Oct 1;189(7):3397-403. Epub 2012 Aug 22.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk